| Date Filed | Type | Description |
| 11/14/2022 |
4
| JORDEN DAVID EMERSON (CEO/CFO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Sold 30,000 shares
@ $1.5, valued at
$45k
Sold 27,000 shares
@ $1.5, valued at
$40.5k
Sold 20,000 shares
@ $1.5, valued at
$30k
Sold 13,500 shares
@ $1.5, valued at
$20.3k
Sold 10,000 shares
@ $1.5, valued at
$15k
Sold 7,000 shares
@ $1.5, valued at
$10.5k
Sold 5,000 shares
@ $1.5, valued at
$7.5k
|
|
| 07/05/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2022 |
4
| JORDEN DAVID EMERSON (CEO/CFO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 66,672 options to buy
@ $0.5, valued at
$33.3k
Granted 125,000 options to buy
@ $0.75, valued at
$93.8k
|
|
| 04/26/2022 |
5
| JORDEN DAVID EMERSON (CEO/CFO) has filed a Form 5 on Nuo Therapeutics, Inc. |
| 04/26/2022 |
5
| JORDEN DAVID EMERSON (CEO/CFO) has filed a Form 5 on Nuo Therapeutics, Inc. |
| 04/26/2022 |
5
| JORDEN DAVID EMERSON (CEO/CFO) has filed a Form 5 on Nuo Therapeutics, Inc. |
| 01/03/2019 |
4
| JORDEN DAVID EMERSON (CEO, CFO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $0.4, valued at
$50k
|
|
| 08/13/2018 |
4
| JORDEN DAVID EMERSON (CEO, CFO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 192,710 options to buy
@ $0.4, valued at
$77.1k
|
|
| 08/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2017 |
4
| JORDEN DAVID EMERSON (Acting CFO) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Bought 32,727 shares
@ $6.875, valued at
$225k
Bought 32,727 warrants
@ $7.5, valued at
$245.5k
|
|
| 04/20/2017 |
4
| JORDEN DAVID EMERSON (Acting CFO) has filed a Form 4 on PLx Pharma Inc. |
| 04/20/2017 |
3
| JORDEN DAVID EMERSON (Acting CFO) has filed a Form 3 on PLx Pharma Inc. |
| 01/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/15/2015 |
4
| JORDEN DAVID EMERSON (Acting CFO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.21, valued at
$52.5k
|
|
| 09/26/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/02/2013 |
4
| JORDEN DAVID EMERSON (Director) has filed a Form 4 on Opexa Therapeutics, Inc.|
Txns:
| Granted 4,450 shares
@ $1.54, valued at
$6.9k
|
|
| 05/21/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/01/2013 |
4
| JORDEN DAVID EMERSON (Director) has filed a Form 4 on Opexa Therapeutics, Inc.|
Txns:
| Granted 5,000 options to buy
@ $1.75, valued at
$8.8k
Granted 17,143 options to buy
@ $1.75, valued at
$30k
|
|
| 02/27/2013 |
4
| JORDEN DAVID EMERSON (Acting CFO) has filed a Form 4 on Opexa Therapeutics, Inc.|
Txns:
| Disposed/sold convertible notes
@ $1.3, valued at
$0 |
|
| 02/27/2013 |
4
| JORDEN DAVID EMERSON (Director) has filed a Form 4 on CYTOMEDIX INC|
Txns:
| Bought 20,600 shares
@ $0.52, valued at
$10.7k
Bought 4,400 shares
@ $0.53, valued at
$2.3k
Bought 20,600 shares
@ $0.52, valued at
$10.7k
Bought 4,400 shares
@ $0.53, valued at
$2.3k
|
|
| 02/22/2013 |
4
| JORDEN DAVID EMERSON (Director) has filed a Form 4 on CYTOMEDIX INC|
Txns:
| Bought 30,000 shares
@ $0.53, valued at
$15.9k
Bought 20,000 shares
@ $0.53, valued at
$10.6k
|
|
| 01/24/2013 |
4
| JORDEN DAVID EMERSON (Acting CFO) has filed a Form 4 on Opexa Therapeutics, Inc.|
Txns:
| Granted 4,595 shares
@ $1.33, valued at
$6.1k
Granted convertible notes
@ $1.3, valued at
$0
Granted 37,500 warrants
@ $1.24, valued at
$46.5k
|
|
| 09/14/2012 |
4
| JORDEN DAVID EMERSON (Director) has filed a Form 4 on CYTOMEDIX INC|
Txns:
| Bought 25,000 shares
@ $0.89, valued at
$22.3k
|
|
| 09/12/2012 |
4
| JORDEN DAVID EMERSON (Director) has filed a Form 4 on CYTOMEDIX INC|
Txns:
| Bought 8,333 shares
@ $0.95, valued at
$7.9k
|
|
| 08/31/2012 |
4
| JORDEN DAVID EMERSON (Director) has filed a Form 4 on CYTOMEDIX INC|
Txns:
| Exercised (in-or-at-the-money) 16,667 shares
@ $1, valued at
$16.7k
Exercised (in-or-at-the-money) 16,667 warrants
@ $0 |
|
| 08/16/2012 |
4
| JORDEN DAVID EMERSON (Acting CFO) has filed a Form 4 on Opexa Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $0.51, valued at
$38.3k
|
|
| 07/27/2012 |
4
| JORDEN DAVID EMERSON (Director) has filed a Form 4 on Opexa Therapeutics, Inc.|
Txns:
| Granted options to buy
@ $100, valued at
$0
Granted 107,813 warrants
@ $1.25, valued at
$134.8k
|
|
| 03/05/2012 |
4
| JORDEN DAVID EMERSON (Director) has filed a Form 4 on Opexa Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $0.94, valued at
$9.4k
Granted 20,600 options to buy
@ $0.94, valued at
$19.4k
|
|
| 01/30/2012 |
4
| JORDEN DAVID EMERSON (10% Owner) has filed a Form 4 on CYTOMEDIX INC|
Txns:
| Acquired 1,854 shares
@ $0 |
|
| 12/06/2011 |
4
| JORDEN DAVID EMERSON (10% Owner) has filed a Form 4 on CYTOMEDIX INC|
Txns:
| Granted 50,000 options to buy
@ $0.8, valued at
$40k
|
|
| 10/17/2011 |
4
| JORDEN DAVID EMERSON (10% Owner) has filed a Form 4 on CYTOMEDIX INC|
Txns:
| Acquired 3,793 shares
@ $0 |
|
| 07/18/2011 |
4
| JORDEN DAVID EMERSON (10% Owner) has filed a Form 4 on CYTOMEDIX INC|
Txns:
| Acquired 5,000 shares
@ $0 |
|
| 06/07/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|